We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDMO
1676
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.06M ﹤0.01%
85,600
-407,557
-83% -$4.67M
FTAI icon
1677
FTAI Aviation
FTAI
$20.6B
$1.05M ﹤0.01%
7,321
-9,322
-56% -$1.37M
SHEN icon
1678
Shenandoah Telecom
SHEN
$640M
$1.05M ﹤0.01%
+83,400
New +$1.12M
MXCT icon
1679
MaxCyte
MXCT
$108M
$1.05M ﹤0.01%
252,333
+29,739
+13% +$112K
SYK icon
1680
Stryker
SYK
$134B
$1.04M ﹤0.01%
2,902
-11,749
-80% -$4.35M
USAP
1681
DELISTED
Universal Stainless & Alloy
USAP
$1.04M ﹤0.01%
23,707
-8,820
-27% -$381K
NBR icon
1682
Nabors Industries
NBR
$1.17B
$1.04M ﹤0.01%
+18,221
New +$1.29M
GLDD
1683
DELISTED
Great Lakes Dredge & Dock
GLDD
$1.04M ﹤0.01%
92,197
-165,940
-64% -$1.99M
HIMS icon
1684
Hims & Hers Health
HIMS
$6.48B
$1.04M ﹤0.01%
43,028
-1,572,345
-97% -$39M
CCRD
1685
DELISTED
CoreCard
CCRD
$1.04M ﹤0.01%
45,810
+12,225
+36% +$216K
TCBX icon
1686
Third Coast Bancshares
TCBX
$728M
$1.04M ﹤0.01%
+30,558
New +$994K
ALGT icon
1687
Allegiant Air
ALGT
$2.63B
$1.04M ﹤0.01%
11,010
+5,209
+90% +$380K
DXC icon
1688
DXC Technology
DXC
$1.85B
$1.04M ﹤0.01%
51,817
-242,843
-82% -$5.12M
EWQ icon
1689
iShares MSCI France ETF
EWQ
$325M
$1.03M ﹤0.01%
+28,844
New +$1.08M
NFBK
1690
DELISTED
Northfield Bancorp
NFBK
$1.03M ﹤0.01%
88,854
-67,131
-43% -$835K
AVNS icon
1691
Avanos Medical
AVNS
$1.03M ﹤0.01%
+64,765
New +$1.28M
BKR icon
1692
Baker Hughes
BKR
$59.3B
$1.03M ﹤0.01%
25,100
-558,968
-96% -$22.5M
FIBK icon
1693
First Interstate BancSystem
FIBK
$3.69B
$1.03M ﹤0.01%
+31,670
New +$1.03M
CF icon
1694
CF Industries
CF
$19.5B
$1.03M ﹤0.01%
12,052
-3,338
-22% -$289K
CRNC icon
1695
Cerence
CRNC
$362M
$1.03M ﹤0.01%
130,640
-56,519
-30% -$284K
GEF icon
1696
Greif
GEF
$4.76B
$1.03M ﹤0.01%
+16,778
New +$1.1M
GGG icon
1697
Graco
GGG
$13.2B
$1.02M ﹤0.01%
12,124
-23,961
-66% -$2.08M
MQ icon
1698
Marqeta
MQ
$1.9B
$1.02M ﹤0.01%
67,070
-69,079
-51% -$1.21M
GOLD
1699
Gold.com Inc
GOLD
$1.15B
$1.02M ﹤0.01%
37,053
-36,572
-50% -$1.24M
VLY icon
1700
Valley National Bancorp
VLY
$8B
$1.01M ﹤0.01%
111,660
+64,260
+136% +$623K

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.